BEAT: HeartBeam, Inc. - Summary | Jitta

HeartBeam, Inc.

NASDAQ:BEAT

Price
$2.20
Loss Chance
58.1%
0.48JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
893 / 1,181
4,540 / 4,991
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (0)
Recent Business Performance (6)
Financial Strength (32)
Return to Shareholders (0)
Competitive Advantage (2)
Jitta Signs
SG&A to SalesDecreasing Every Year
Cash Conversion CycleLess than 30 days
Recent IPOLess than 3 years
Recent Business PerformanceEarning decline 66.07% in the last quarter (yoy)
SG&A to SalesIncreasing Every Year
Key Stats
Jitta Score
Jitta Line
0.48
100.00%
1.95
183.64%
Health Care Equipment
4.79
> 1,000%
4.57
33.85%
5.93
36.24%
COMPANY DESCRIPTION
HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company develops three-dimensional (3D)-vector electrocardiogram (ECG) platform for heart attack detection. It is developing HeartBeam AIMI software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack; and HeartBeam AIMIGo, a credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.